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Abstract
Objective
To describe the ﬁndings of histopathology and genotyping studies in aﬀected brain tissue from
an individual with phacomatosis pigmentovascularis (PPV).
Methods
A retrospective chart review of a 2-year 10-month-old male with a clinical diagnosis of PPV
cesiomarmorata (or type V) was performed. Clinical features, brain imaging and histopathology
ﬁndings, and genotyping studies in his aﬀected brain tissue are summarized.
Results
The proband had a clinically severe neurologic phenotype characterized by global de-
velopmental delay, generalized hypotonia, and recurrent episodes of cardiac asystole in the
setting of status epilepticus. A somatic pathogenic variant inGNA11 (c.547C>T, p.Arg183Cys)
was detected in his skin tissue but not in blood (previously published). He underwent an urgent
left posterior quadrantectomy for his life-threatening seizures. Histopathology of resected brain
tissue showed an increase in leptomeningeal melanocytes and abnormal vasculature, and the
exact pathogenic variant inGNA11 (c.547C>T, p.Arg183Cys), previously isolated from his skin
tissue but not blood, was detected in his resected brain tissue.
Conclusions
The ﬁnding of this variant in aﬀected skin and brain tissue of our patient with PPV supports
a unifying genetic diagnosis of his neurocutaneous features.
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Phacomatosis pigmentovascularis (PPV) is a group of rare cu-
taneous syndromes characterized by coexisting widespread
vascular and pigmentary lesions of diﬀerent types.1,2 PPV is
currently classiﬁed into 3 or 5 types depending on the combi-
nation of skin features, but additional systemic features are often
observed.2 In a study of 24 individuals, clinical and radiologic
CNS features were noted in 60% of PPV cases.3 Reported CNS
features are similar but not identical to those described in the
closely related Sturge-Weber syndrome (SWS) and include
seizures, global developmental delay (GDD), intellectual dis-
ability, cortical atrophy, asymmetric hemispheres, intracranial
hypertension, hydrocephalus, ventriculomegaly, brain calciﬁca-
tions, abnormal EEG, congenital hearing loss, and spina
biﬁda.3–6 Because of the rarity of PPV and themultiple subtypes,
the neurologic features have not been extensively characterized.
Recently, somatic variants have been identiﬁed in several neu-
rocutaneous syndromes (NCSs), including somatic GNAQ var-
iants in SWS.7,8 Subsequently, somaticGNA11orGNAQ variants
were identiﬁed inmultiple skin lesions (pigmentary and vascular)
and ocular tissue, but not in blood, in a cohort with PPV and
a related cutaneous diagnosis, extensive dermal melanocytosis.1
In this report, we describe a life-threatening neurologic phe-
notype with recurrent status epilepticus and cardiac asystole
in a 2-year 10-month-old male with PPV, in which a GNA11
variant was identiﬁed in brain and skin but absent in blood.
Somatic brainGNA11 pathogenic variant may be identiﬁed in
the brain of individuals with PPV.
Methods
We performed a retrospective chart review of an individual with
PPV. We summarize his clinical features, brain imaging and his-
topathology ﬁndings, and genotyping studies in his brain tissue.
Standard protocol approvals, registrations,
and patient consents
Permission to publish the case was obtained from the legal
guardian of the individual participating in the study. We have
also obtained authorization for disclosure of the recognizable
photographs that are published in the Journal, in derivative
works by the American Academy of Neurology, or on the
Journal’s website. This work does not include any experiments
involving human subjects.
Data availability
Any unpublished clinical data including clinical pictures,
neurophysiology studies, brain images, histopathology slides,
and molecular studies can be deidentiﬁed and made available
upon request.
Clinical report
The proband is a fraternal twin conceived by in vitro fertil-
ization to Middle Eastern consanguineous parents. Pregnancy
was complicated by advanced paternal age, gestational hy-
pertension, and twin-twin transfusion with intrauterine
growth restriction in the proband, leading to an urgent ce-
sarean section at 33 weeks. Birth weight was 1.8 kg (29th
percentile, z = −0.49). Postnatally, he required respiratory
support in the neonatal intensive care unit for 10 days. At age
4 months, he was noted to have poor vision and underwent
trabeculectomy for bilateral congenital glaucoma.
At age 15 months, he was hospitalized twice for two separate
episodes of cyanosis and apnea after emesis, with the second
episode leading to cardiac arrest requiring resuscitation. He
had extensive workup including a 1.5-T brain MRI that
showed cerebral atrophy, hypomyelination, corpus callosum
hypoplasia, left lateral ventricle enlargement, and bilateral
optic nerve hypoplasia. EEG revealed diﬀuse background
slowing without epileptiform activity. Holter monitoring
captured an episode of apnea without cardiac arrhythmias,
and echocardiogram showed a questionable mass on the right
ventricular wall with normal systolic function and no re-
gurgitation. Renal ultrasound showed small left lower renal
pole and interpolar cortical cysts, two right-sided renal
arteries, and left renal artery stenosis, for which he underwent
balloon dilation. CT of the chest showed atelectasis of the
right lung apex and left lung base suggesting recurrent aspi-
rations, and a swallow study demonstrated microaspiration of
ﬂuids. Subsequently, the episodes were attributed to gastro-
esophageal reﬂux disorder, and he underwent a Nissen fun-
doplication at age 23 months.
Within 1 month, he had recurrence of the apneic episodes
without preceding emesis but with blank stares and pro-
gression to right arm and leg stiﬀening and superimposed
tremulousness, unmasking his seizures. Oxcarbazepine was
initiated, but he continued to experience prolonged seizures
with cardiac asystole requiring resuscitation on 2 additional
occasions.
A thorough examination revealed dysmorphic features and
skin abnormalities (ﬁgure 1). Magnetic resonance angiogra-
phy, venography, and spectroscopy of the brain were normal.
Neurologic examination was notable for marked GDD and
generalized hypotonia. At age 2 years, he was nonverbal,
Glossary
AAF = alternate allele read frequency; AED = antiepileptic drug; ES = exome sequencing; GDD = global developmental delay;
NCS = neurocutaneous syndrome; PPV = phacomatosis pigmentovascularis; SWS = Sturge-Weber syndrome;VUS = variant of
unknown signiﬁcance.
2 Neurology: Genetics | Volume 5, Number 6 | December 2019 Neurology.org/NG
barely sitting unsupported, and had a palmar grasp and re-
ciprocal smile. His vision was poor.
A comprehensive presurgical epilepsy workup (ﬁgure 1) was
consistent with multifocal epilepsy with evidence for ictal
onset from the left posterior quadrant. A 78-hour EEG study
captured an hour-long autonomic status epilepticus arising
from the left occipital region following withdrawal of his an-
tiepileptic drug (AED). Semiology consisted of sudden-onset
tachycardia, with resting heart rate doubling from 78 to 132
beats per minute within seconds. Multifocal epileptiform or
paroxysmal fast activity over the bilateral frontocentral, left
occipital, and left posterior temporal regions were also ob-
served. Ictal/interictal subtraction single-photon emission
computerized tomography was unsuccessful in eliciting an
ictal focus. Clobazam was added to his AED regimen.
Trio exome sequencing (ES) (peripheral blood) to evaluate the
cause of his seizures and cardiac asystole episodes identiﬁed
a paternally inherited heterozygous variant of unknown sig-
niﬁcance (VUS) in DSG2 (c.650C>T, p.Thr217Ile), a gene
associated with autosomal dominant arrhythmogenic right
ventricular dysplasia. Mitochondrial genome sequencing and
chromosomal microarray were non-informative. In a previously
published study, our patient (patient 8 in table 1 of the previous
study), who had been diagnosed with PPV cesiomarmorata (or
type V) due to pigmentary lesions on his trunk and vascular
lesions on his face, trunk, and limbs, underwent genetic testing.
Low-level mosaicism for a pathogenic variant in GNA11
(c.547C>T, p.Arg183Cys) was identiﬁed in the DNA extracted
from biopsies of his pigmentary and vascular cutaneous lesions
(alternate allele read frequency [AAF] of 15.5% and 9.6%, re-
spectively), but was not detected in his blood.1 Moreover,
a reevaluation of his ES data did not identify any alternate allele
reads despite 281× coverage.
Stereotactic depth electrode placement for intracranial EEG
monitoring was not performed because of hypotension in the
operating room requiring multiple vasopressors. Given his
life-threating seizures, a multidisciplinary team agreed that an
urgent palliative left posterior quadrantectomy was necessary
while his AED doses were increased.
During resection at age 2 years 10 months, brain tissue at the
surgical site was discolored (i.e., greenish purple) with abnor-
mal vasculature. Histopathology of the resected medial occip-
ital lobe, superior temporal gyrus, hippocampus, and amygdala
tissue revealed mild cortical dysplasia without balloon cells,
Figure 1 Clinical features and imaging findings
(A) Face and skin findings. Long eyelashes and flat nasal bridge were noted. In addition, he had scleral hyperpigmentation and telangiectasia on both cheeks.
(B) Hemihypertrophy of the right arm. (C) Hemihypertrophy of the right leg. (D) Additional skin findings. Cerulean-colored and blanchable, mottled violaceous
to erythematous patches on the chest, abdomen, back, and buttocks (not shown). (E) 3T brain MRI (T1 sequence, axial view) shows cerebral atrophy and left
lateral ventricle enlargement. (F) 3T brain MRI (FLAIR sequence, coronal view) shows T2 hyperintensity of the left hippocampus (white arrow) and subtle T2
hyperintensity of the right hippocampus (white arrowhead) raising concern for left more than right mesial temporal sclerosis. (G) 3T brain MRI (T2 sequence,
coronal view) redemonstrates the T2 hyperintensity of the left hippocampus (blue arrow) and subtle T2 hyperintensity of the right hippocampus (blue
arrowhead) raising concern for early leftmore than rightmesial temporal sclerosis. (H) Positron emission tomography elicits a global reduction in Fluorine-18
fluorodeoxyglucose radiotracer uptake over the left hemisphere, particularly left medial temporal lobe. (I) Magnetic encephalography (MEG) performed as
part of presurgical epilepsy workup showing a large cluster of MEG sharp waves within the left mesial parieto-occipital sulcus and a small cluster on the right
homologous region. FLAIR = fluid-attenuated inversion recovery.
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diﬀuse neuronal heterotopia, reactive gliosis, and increased
leptomeningeal melanocytes similar to that observed in the
cutaneous lesions (ﬁgure 2). Targeted next-generation se-
quencing of DNA from resected tissue (medial left occipital
lobe) identiﬁed the exact GNA11 variant detected in skin with
AAF of 12.9% (1881× coverage).
Postoperatively, the patient had immediate and prolonged
seizure freedom lasting for 17 months (Engel 1 classiﬁcation)
with interval development of a moderate right-sided weak-
ness. A follow-up EEG showed diﬀuse background slowing,
multifocal epileptiform discharges, and expected continuous
left posterior quadrant slowing. Postsurgical brain MRI
showed resolution of the right hippocampus hyperintensity
(ﬁgure 3).
Discussion
Our patient had PPV with life-threatening recurrent status
epilepticus with presumably ictal asystole. Epilepsy and other
neurologic features have been described in PPV, although the
extent and severity at cohort level are not well documented.3,4,6
On the other hand, life-threatening seizures such as apneic
seizures are observed in the closely related SWS.5 However, our
patient only had cutaneous signs of PPV with intracranial in-
volvement, and no evidence for leptomeningeal angiomatosis
or facial capillary malformation, typically seen in SWS, was
found. In addition, GNA11 somatic variants can cause a range
of cutaneous disorders with or without extracutaneous mani-
festations that are not fully understood.6 Thus, our patient may
represent the severe end of the spectrum of neurologic features
in GNA11-related disorders.
Alternatively, a second diagnosis may explain his neurologic
features and asystole episodes. In particular, the contribution of
the paternally inheritedDSG2 VUS to the phenotype is unclear,
although the proband’s father is asymptomatic. However, the
identiﬁcation of the somatic GNA11 variant in his cerebral tis-
sue, the immediate and prolonged seizure freedom, and the
resolution of his asystole episodes postresection supports
a single pathomechanism. This observation would be best
conﬁrmed with a longer follow-up and an AED withdrawal
challenge.
The interval resolution of the right hippocampal hyperintensity
on postoperative brain MRI may be secondary to seizure res-
olution. However, the increased melanocytes in the lep-
tomeninges are a newly described and important aspect of the
neurologic features of PPV, mirroring the coexistence of both
pigmentary and vascular lesions on the skin. This ﬁnding fur-
ther supports the hypothesis that the melanocytes are the
primary carrier of this somatic mutation and possibly contrib-
utes to the severity of neurologic disease in this case of PPV.
This is usually only described in a genetically distinct pig-
mentary mosaic condition multiple congenital melanocytic
nevi,9,10 where it leads to seizures and GDD. No evidence of
intraparenchymal melanosis was seen on histopathology of the
left mesial temporal specimen.
Somatic variants in GNA11 have been previously isolated
from skin but not brain parenchyma in PPV.1 There is
growing evidence for brain somatic variants in other NCSs
and nonlesional and lesional epilepsies including a spectrum
of epileptic neurodevelopmental malformations ranging from
isolated focal cortical dysplasia to bilateral brain
overgrowth.7,10–12 The presence of theGNA11 variant in only
brain and skin tissue is consistent with an early somatic mu-
tation.12 Detection of such low-level mosaicism requires
coupling advanced and sensitive sequencing technology with
accurate tissue selection.12
Our case expands the clinical and molecular spectrum of PPV
and GNA11-related disorders. However, our study has a few
limitations because it represents a single case report with
a short follow-up period. An in-depth understanding of the
neurologic features and conﬁrmation of this molecular ﬁnding
will require a larger PPV cohort.
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Figure 3 Pre- and post-surgical brain MRI
(A) Presurgical MRI (FLAIR sequence, coronal view)
showing the T2 hyperintensity of the left hippo-
campus (blue arrow) and subtle T2hyperintensity of
the right hippocampus (blue arrowhead). (B) Post-
surgical MRI (FLAIR sequence, coronal view) showing
a surgical cavity on the left temporal region and re-
solution of the T2 hyperintensity of the right hippo-
campus (blue arrowhead). FLAIR = fluid-attenuated
inversion recovery.
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